Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Developmental Neuroscience
|
September 7, 2011
On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome
Alberto C S Costa
CNS & Neurological Disorders Drug Targets
|
October 25, 2013
The glutamatergic hypothesis for Down syndrome: the potential use of N-methyl-D-aspartate receptor antagonists to enhance cognition and decelerate neurodegeneration
Alberto C S Costa
Brain Sciences
|
November 27, 2024
On the Therapeutic Use of Monoclonal Antibodies Against Amyloid Plaques in Older Adults with Down Syndrome: A Narrative Review and Perspective
Alberto C S Costa
Experimental Brain Research
|
August 16, 2011
An assessment of the vestibulo-ocular reflex (VOR) in persons with Down syndrome
Alberto C S Costa
Experimental Brain Research
|
August 16, 2011
An assessment of optokinetic nystagmus (OKN) in persons with Down syndrome
Alberto C S Costa
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
October 19, 2006
The proteins of human chromosome 21
Katheleen Gardiner, Alberto C S Costa
Nature Reviews. Genetics
|
January 11, 2005
Down syndrome and genetics - a case of linked histories
David Patterson, Alberto C S Costa
Brain Sciences
|
January 21, 2022
Evidence of Energy Metabolism Alterations in Cultured Neonatal Astrocytes Derived from the Ts65Dn Mouse Model of Down Syndrome
Bruna L Zampieri, Alberto C S Costa
Behavioural Brain Research
|
August 11, 2004
Experimental parameters affecting the Morris water maze performance of a mouse model of Down syndrome
Melissa R Stasko, Alberto C S Costa
Neuroscience Letters
|
June 1, 2005
Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome
Alberto C S Costa, Michael J Grybko
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Developmental Neuroscience
|
September 7, 2011
On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome
Alberto C S Costa
CNS & Neurological Disorders Drug Targets
|
October 25, 2013
The glutamatergic hypothesis for Down syndrome: the potential use of N-methyl-D-aspartate receptor antagonists to enhance cognition and decelerate neurodegeneration
Alberto C S Costa
Brain Sciences
|
November 27, 2024
On the Therapeutic Use of Monoclonal Antibodies Against Amyloid Plaques in Older Adults with Down Syndrome: A Narrative Review and Perspective
Alberto C S Costa
Experimental Brain Research
|
August 16, 2011
An assessment of the vestibulo-ocular reflex (VOR) in persons with Down syndrome
Alberto C S Costa
Experimental Brain Research
|
August 16, 2011
An assessment of optokinetic nystagmus (OKN) in persons with Down syndrome
Alberto C S Costa
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
October 19, 2006
The proteins of human chromosome 21
Katheleen Gardiner, Alberto C S Costa
Nature Reviews. Genetics
|
January 11, 2005
Down syndrome and genetics - a case of linked histories
David Patterson, Alberto C S Costa
Brain Sciences
|
January 21, 2022
Evidence of Energy Metabolism Alterations in Cultured Neonatal Astrocytes Derived from the Ts65Dn Mouse Model of Down Syndrome
Bruna L Zampieri, Alberto C S Costa
Behavioural Brain Research
|
August 11, 2004
Experimental parameters affecting the Morris water maze performance of a mouse model of Down syndrome
Melissa R Stasko, Alberto C S Costa
Neuroscience Letters
|
June 1, 2005
Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome
Alberto C S Costa, Michael J Grybko
Page
of 5